Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)

NCT07468448 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1172

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Intracranial Atherosclerosis

Interventions

DRUG: Rivaroxaban
DRUG: ASA

Sponsor

Population Health Research Institute